AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04019093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ethanol
Description: A beverage containing dose of ethanol individually determined to raise a participant's breath alcohol concentration up to approximately 0.08 g/dL.
Study NCT03015974 — intervention group
Intervention type: DRUG
Intervention: Mycophenolate mofetil
Study NCT03015974 — intervention group
Intervention type: DRUG
Intervention: Dipyridamole
Study NCT03015974 — intervention group
Intervention type: DRUG
Intervention: ACE Inhibitor or Angiotensin receptor antagonist
Study NCT04019093 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: A beverage that does not meaningfully increase breath alcohol concentration.
Study NCT04561635 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Multiple-micronutrients supplement
Description: Multiple-micronutrients supplement with 15 micronutrients
Study NCT02756390 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBTI-CS
Description: CBTI-CS is a multi-modal intervention designed to address both cognitive and behavioral factors that perpetuate insomnia. Cognitive factors are addressed via cognitive restructuring and psychoeducation. Behavioral factors are addressed by structured sleep restriction, stimulus control and sleep hygiene techniques. Cancer treatment late-effects affecting sleep are addressed as potential contributors to these cognitive and behavioral factors, and as symptoms that may benefit from referral for medical evaluation/management. Participants are instructed in these cognitive-behavioral strategies as a group, but using analysis of personal sleep-log data, symptom self-reports and targeted workbook exercises, they are helped to tailor the intervention to address their specific needs.
Study NCT02756390 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Hygiene
Description: Education on health behaviors, sleep habits and environmental practices intended to promote good quality sleep. Recommendations target exercise and natural light exposure,use of stimulants and alcohol, daytime napping, timing of meals, creating a comfortable non-stimulating sleep space, and creating sleep rituals.
Study NCT02756390 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: CBTI-CS via Telehealth
Description: The CBTI-CS intervention, a multi-modal intervention designed to address both cognitive and behavioral factors that perpetuate insomnia, will be administered via live video. conferencing. Participants will have a single in-person training session and subsequent CBTI-CS group sessions will be conducted by live video conference.
Study NCT01743963 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Decision support
Description: Clinical pharmacists mediated computerized decision support
Study NCT05395949 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: conservative treatment
Description: Prednisone 30 mg/day, supplemented with calcium and omeprazole, and Prednisone were slowly reduced to 10 mg/day after symptoms were relieved, and combined with 7.5 mg/week MTX therapy.
Study NCT02169102 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No additional Intervention (control)
Description: No additional intervention previously to the urgency endodontic treatment (Control)
Study NCT02169102 — intervention group
Intervention type: RADIATION
Group type: SHAM_COMPARATOR
Intervention: Sham Laser Irradiation
Description: Fifteen minutes previously the urgency endodontic treatment, sham laser irradiation was performed in the tooth with irreversible inflammation in pulp.
Study NCT02169102 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Laser 1 (at 0,16 Joules/point of irradiation)
Description: Fifteen minutes previously the urgency endodontic treatment, laser irradiation will be performed in the tooth with irreversible inflammation in pulp at 0,16 Joules/point at 2 points (perpendicularly to tooth crown and in periapex region)
Study NCT02169102 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Laser 2 (1,6 Joules/point of irradiation)
Description: Fifteen minutes previously the urgency endodontic treatment, laser irradiation will be performed in the tooth with irreversible inflammation in pulp at 1,6 Joules/point at 2 points (perpendicularly to tooth crown and in periapex region)
Study NCT00652119 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Cycle 1 = 60 mg/m\^2 IV weekly over 1 hour x 3 weeks; Cycles 2-6 = 60 mg/m\^2 IP weekly over 1 hour x 3 weeks of each cycle.
Study NCT00652119 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Cycle 1 = AUC 6 IV over 1 hour on day 1; Cycles 2-6 = AUC 6 IP over 1 hour on day 1 of each cycle.
Study NCT00652119 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avastin
Description: Cycle 2 = 15 mg/kg IV over 90 minutes on day 8; Cycles 3-6 = 15 mg/kg IV on day 1 of each cycle.
Study NCT02780245 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid
Description: At 20 minutes preoperatively, TXA of 20 mg/kg was administered in Z Solution (500•0 ml normal saline containing a prophylactic antibiotic 1•0 g).
Study NCT02780245 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intraoperative Uterine Cooling
Description: Intraoperatively immediately following delivery of the fetus the uterus was been externalized in the usual fashion, and the body of the uterus cephalad to the hysterotomy incision was been wrapped in sterile surgical towels saturated in sterile and iced normal saline. These towels came from a sterile cooling pot set to 30 degrees Fahrenheit. Iced saline-soaked towels was been kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen.
Study NCT02864095 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid (TXA)
Description: IV and topical administration
Study NCT02864095 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Description: IV and topical administration
Study NCT02864095 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrine
Study NCT01363362 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Selective Laser Trabeculoplasty
Description: 360° selective laser trabeculoplasty, 100 non-overlapping spots, energy 0,5-1,2 mJ
Study NCT01524536 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: prednisone
Description: Glucocorticoids (GC) are considered the first- line therapy for hypereosinophilic syndrome.
Study NCT04176458 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Methacetin Breath Test (MBT)
Description: The hypothesis is that MBT CPDR 20 in the Fontan patient is abnormal as a result of alterations in liver perfusion, liver cell metabolic capability and transhepatic resistance secondary to hemodynamics unique to the Fontan as well as end-organ liver damage. Due to lack of robust biomarkers or other risk stratification schemes, we aim to determine whether there is prognostic value in hepatic MBT CPDR 20 in the Fontan patient.
Study NCT01188252 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Roniciclib (BAY1000394)
Description: Oral administration twice daily in a 3 days on / 4 days off schedule. Starting dose will be 0.3 mg corresponding to approximately 0.005 mg/kg and dose will be escalated dependent on any dose limiting toxicities.
Study NCT02260310 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Weizhong and Huantiao
Study NCT02260310 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: A-shi point
Study NCT01457560 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DTPa-HBV-IPV/Hib (Infanrix hexa™)
Description: Three doses administered intramuscularly
Study NCT01457560 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: OPV
Description: One dose administered orally
Study NCT02740530 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magstim® Rapid 2 machine
Description: See Arms description
Study NCT02740530 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Magstim® Rapid 2 machine
Description: See Arms description
Study NCT01910636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sofosbuvir
Description: Sofosbuvir 400 mg tablet administered orally once daily
Study NCT01910636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RBV
Description: Ribavirin (RBV) tablets were administered orally in a divided daily dose according to package insert weight-based dosing according to the approved Copegus labeling in Japan (\< 60 kg = 600 mg , > 60 kg to ≤ 80 kg = 800 mg, and ≥ 80 kg = 1000 mg)
Study NCT00844571 — intervention group
Intervention type: OTHER
Intervention: E-learning program
Description: Participants are committed to accomplish the program in approximately 2 hours. Additionally to these mandatory hours, they were able to access the e-learning program at any time and place.
Study NCT03008499 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: High-activity natural killer
Description: Each treatment: 8\~10 billion cells in all, transfuion in 3 times, i.v.
Study NCT03035045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol
Study NCT03035045 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Study NCT06081231 — intervention group
Intervention type: DEVICE
Intervention: open-source APS;
Description: a continuous glucose monitoring system, an insulin pump, and an intelligent algorithm.
Study NCT02888249 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Altered composition cigarette
Description: This double-blind study will systematically determine the abuse liability of altered composition cigarettes using a behavioral economics abuse-liability approach. Altered composition cigarettes (e.g., cigarettes differing in casings, sugars, tar levels, moisture) may result in decreased intake and decreased dependence, although critical questions remain regarding the abuse-liability of altered composition cigarettes, whether exposure to these cigarettes reduces use, and whether altered composition cigarettes will substitute for standard cigarettes. The addictive effects and abuse liability of altered composition cigarettes, therefore, are not well understood, and will be tested in this study.
Study NCT02854761 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EF-022 (Modified Vitamin D Binding Protein Macrophage Activator)
Study NCT04025138 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular fatigue assessment test
Description: Neuromuscular fatigue assessment test in dynamic mode will be assessed by the Force/Velocity Profile (FVP) measure: 2 sprints of 8 seconds on a cycle ergometer.
Study NCT01703130 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dose of of ropivacaine 0.75% used in block procedure
Study NCT01685528 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT
Description: 6-8 weekly sessions of CBT, 1 of which is in person with the rest being over the telephone
Study NCT02274493 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: da Vinci® Robotic Surgical System
Description: Da Vinci Robotic Surgical system to be used in procedures that harvest the latissimus dorsi muscle for reconstructive procedures
Study NCT02274493 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: LD muscle flap harvest procedure
Description: Latissimus dorsi muscle flap harvest procedure using da Vinci® Robotic Surgical System for use in reconstructive surgery.
Study NCT02274493 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reconstructive surgery
Description: Reconstructive surgery is considered to be standard of care.
Study NCT02274493 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Questionnaire about pain, as well as participant's shoulder, arm, and hand range of motion completed at baseline, and at follow up visits 3-6.
Study NCT01295918 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: L reuteri in children on antibiotics
Description: Each patient will be assigned to receive either a probiotic supplement containing 1 x 10 8 CFU Lactobacillus reuteri DSM 17938 in the form of one chewable tablet once per day (BioGaia AB, Stockholm, Sweden) or placebo, identical in taste and appearance. The probiotic or placebo will be taken 2 hours after lunch each day, during the entire period of antibiotic treatment and for an additional 7 days.
Study NCT03014830 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alirocumab
Description: 150 mg SQ every 2 weeks
Study NCT03014830 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: Placebo injections SQ every 2 weeks
Study NCT01616654 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD5789 25 µg/g cream
Description: CD5789 25 µg/g cream applied once daily
Study NCT01616654 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD5789 50 µg/g cream
Description: CD5789 50 µg/g cream applied once daily
Study NCT01616654 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CD5789 100 µg/g cream
Description: CD5789 100 µg/g cream applied once daily
Study NCT01616654 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tazarotene 0.1% gel
Description: Tazarotene 0.1% gel applied once daily
Study NCT01616654 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vehicle cream
Description: Vehicle cream applied once daily
Study NCT03728595 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Venepuncture
Description: A blood sample will be taken for serum bicarbonate
Study NCT03728595 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Spirometry
Description: All patients who have not had a spirometry in the 12 months prior to the HAST will undergo one on the day of the HAST.
Study NCT03728595 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hypoxic altitude simulation test (HAST)
Description: HAST will be performed as per clinical team request. No changes to this intervention will be made for research purposes.
Study NCT01743963 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: clinicians typical apporach for GID monitering
Study NCT00360243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: flibanserin
Description: Experimental: flibanserin 25 mg b.i.d
Study NCT00360243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: flibanserin
Description: Experimental: flibanserin 50mg qhs
Study NCT04025138 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: treadmill
Description: 2 sessions of treadmill will be realized: 8 and 10 km.h-1 for level running and 7 km.h-1 with 10% slope for graded running.
Study NCT00360243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: flibanserin
Description: Experimental: flibanserin 50mg b.i.d.
Study NCT00360243 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study NCT03739463 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: MAG-DHA
Description: 375 MG of MAG-DHA per capsules, two capsules BID
Study NCT03739463 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Oleic acid
Description: 375 MG of sunflower oil (oleic acid) per capsules, two capsules BID
Study NCT00285298 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Study NCT00285298 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04105556 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nursing Care Based on Kolcaba's Comfort Theory
Description: In this study, nursing care based on Kolcaba's Comfort Theory, which continues throughout the perioperative period, was applied to children and their parents.
Study NCT01847833 — intervention group
Intervention type: OTHER
Intervention: MRI scan
Study NCT00868959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lurasidone
Description: Lurasidone 20-120 mg/d Flexibly Dosed - 24 weeks
Study NCT02596711 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine Patch
Description: Participants receive 4 weeks of 21 mg, 4 weeks of 14 mg, and 4 weeks of 7 mg patches.
Study NCT02596711 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Questionnaires regarding tobacco and alcohol use, culture, religion, and sense of control completed at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.
Study NCT02596711 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carbon Monoxide (CO) Test
Description: Carbon monoxide (CO) test given at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.
Study NCT02596711 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Education and Handouts
Description: Participants receive general health education and handouts.
Study NCT02596711 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Culturally Tailored Reading Materials
Description: Participants given reading materials that highlight how aspects of their culture relate to health, smoking and quitting.
Study NCT02596711 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling Sessions
Description: Participants attend 3 counseling sessions during the study.
Study NCT00563004 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: DBCARE
Description: Patients receive dbcare 2 tablets TID for 3 months
Study NCT00563004 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: DBCARE
Description: PLACEBO PILLS 2 TABLETS TID FOR 3 MONTHS
Study NCT04544709 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Low back intradiscal injection of platelet rich plasma (PRP)
Description: SOC Intradiscal Lumbar PRP Procedure : A small amount of blood is drawn from you, then it is spun in a centrifuge to obtain only the platelets and few other cells. After being spun the small amount of platelets will be injected into the specific disc that is believed to be causing pain in an attempt to help reduce inflammation and pain at the site. The injection will be done under fluoroscopic guidance (x-ray) that allows very careful and precise placement of the needle.
Study NCT01465711 — intervention group
Intervention type: PROCEDURE
Intervention: All abdominal surgical procedures
Description: Laparotomy, Laparoscopy
Study NCT01465711 — intervention group
Intervention type: PROCEDURE
Intervention: Intubation
Description: Ventilatory support
Study NCT01465711 — intervention group
Intervention type: RADIATION
Intervention: Imaging
Description: Abdominal ultrasound Computer Tomography Magnetic Resonance Imaging
Study NCT02730507 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surgery with patient-specific rod
Description: Bras A: PSRs must be used with the appropriate instrumentation designed by the same manufacturer. In order to minimize potential bias derived from using different spinal systems or reduction techniques, the posterior instrumentation must be the same (except the use of standard straight rod) in both groups. The surgical method to implement the PSR will be the same as the one to implement the conventional rod. Except for the bending procedure (patient specific rod or conventional rod with perioperative manual bending), the characteristics of implantable devices (biomaterial and diameter of the rod, design, type of screw, etc.) will be the same in each center.
Study NCT04900142 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Micropulsed laser trabeculoplasty
Description: Trabeculoplasty
Study NCT04900142 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Micropulsed laser trabeculoplasty
Description: Trabeculoplasty
Study NCT00798096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fostamatinib Disodium
Description: 200 mg PO BID
Study NCT04025138 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Blood sample will be realized to measure hemorrheologic and hematologic parameters.
Study NCT03080792 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: moderate to high-intensity exercise
Description: 2x per week endurance exercise (continuous moderate and high intensity intervall training on a cycle ergometer) and progressive resistance training (machine based hypertrophy training)
Study NCT03012919 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: active decision support system
Description: The active decision support system in this study is a goal directed therapy (GDT) protocol where threshold hemodynamic values are defined when to give fluid, vasopressors and inotropes. Hemodynamic values are measured with the LiDCOrapid device, which uses pulse contour analysis to continuously monitor cardiac output and respiratory variations in stroke volume (SVV).
Study NCT00522756 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Description: Three ampoules of 7.5% sodium bicarbonate (89.3 mOsm/ampoule; total 150 ml for three ampoules) added to 750 ml of 5% dextrose in water, given at 1 ml/kg/hour through a dedicated intravenous line for 6 hours, and completed prior to the initiation of cardiopulmonary bypass.
Study NCT04025138 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Urinary sample
Description: Urinary sample will be realized to measure hemorrheologic and hematologic parameters.
Study NCT00522756 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium chloride
Description: 0.9% sodium chloride given at 1 ml/kg/hour through a dedicated intravenous line for 6 hours, and completed prior to the initiation of cardiopulmonary bypass.